The consequences of these risks could be severe and maybe even life threatening for some
Keeping past expiry discard vials after expiration or noticeable change
This is a major gap in the research, leaving huge unanswered questions about its safety, side effects, and proper dosage
Novo Nordisk is testing an IL6 inhibitor, Ziltivekimab, which cut hsCRP levels by ~80-90% in the phase 2 trial: The phase 3 trial is measuring the hard outcomes: cardiovascular death, myocardial infarction, or stroke, in people with established cardiovascular disease, chronic kidney disease, and persistent inflammation
When will I feel results, and how long do they last
Notable: Brooksville's deep sterile-compounding expertise translates into reliable peptide quality, even though its peptide menu is still expanding